Operational and Financial Performance
Reshaping how oncology
care is delivered
We're proud to offer Prime Therapeutics' IntegratedRx™ - Oncology to qualified Medically Integrated Dispensing (MID) practices and health system specialty pharmacies through AmerisourceBergen's pharmacy services administrative organizations (PSAOs)
Prime Therapeutics' IntegratedRx™ - Oncology
Helping streamline the treatment pathway
Promoting improved therapy management and reduced interruptions in care
Supporting an enhanced patient experience
Participation requirements for
In addition to data sharing capabilities that allow for demonstration of improved patient care, providers must meet certain requirements as outlined below. For more information, connect with an AmerisourceBergen representative.
Medically Integrated Dispensing
“AmerisourceBergen has been an unwavering supporter of patient choice and flexibility and making cancer treatment accessible at the community level. By participating in this program, our customers have the opportunity to showcase the value of a truly integrated oncology delivery model. This new model will create expanded commercial access to oral oncolytics, enhanced clinical oversight of cancer patients, and will lead to increased administrative efficiencies for providers. We are excited to see how this program shapes the next chapter of cancer care in the U.S.”
Lisa Harrison, RPh
President of Specialty Distribution, AmerisourceBergen
“Prime’s IntegratedRx™ - Oncology program changes the game by enabling providers to dispense patients’ oncology and companion medications in the setting of their choice, promoting improved therapy management and the patient experience."
Matt Wolf, RPh
SVP of Provider Solutions, AmerisourceBergen
Ready to learn more?
Medically Integrated Dispensing (MID) practices
Prime’s IntegratedRx™ model provides Medically Integrated Dispensing practices with an opportunity to demonstrate the value of a truly integrated oncology care model, potentially leading to more positive outcomes for patients and contributing to the sustainability of community oncology.
Learn how Prime’s IntegratedRx™ program – available through Elevate Provider Network – can reshape medication delivery for your complex specialty patients and bring significant potential economic value to your practice.
Health system specialty pharmacies
Prime Therapeutics' IntegratedRx™ - Oncology program is available to qualified health system specialty pharmacies through Accelerate Specialty Network, the Nation's first specialty-focused pharmacy services administrative organization (PSAO).
Accelerate Specialty Network is a specialty-focused PSAO dedicated to enhancing managed care access for a unique network of accredited health system specialty pharmacies, medically integrated dispensing practices, and strategic community-based specialty pharmacies.